<PAGE> 1
Exhibit 23(b)
Consent of Ernst & Young LLP, Independent Auditors
We consent to the incorporation by reference in the Prospectus Supplement dated
October 17, 2000, related to the Registration Statement (Form S-3 No. 333-95181)
of King Pharmaceuticals, Inc. of our report dated January 31, 2000 related to
the consolidated financial statements and schedule of Jones Pharma Incorporated
included in its Annual Report (Form 10-K) for the year ended December 31, 1999
and the Current Report on Form 8-K of King Pharmaceuticals, Inc. dated October
19, 2000, both filed with the Securities and Exchange Commission.
St. Louis, Missouri
October 19, 2000
